Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Frontiers in Psychiatry|November 5, 2019
Antipsychotics for Amphetamine Psychosis. A Systematic ReviewDimy Fluyau, Paroma Mitra, Kervens Lorthe
European Journal of Clinical Pharmacology|March 5, 2022
Selective serotonin reuptake inhibitors in the treatment of depression, anxiety, and post-traumatic stress disorder in substance use disorders: a Bayesian meta-analysisDimy Fluyau, Paroma Mitra, Ankit Jain, et al.
Frontiers in Psychiatry|October 23, 2018
Integrating DSM/ICD, Research Domain Criteria, and Descriptive Psychopathology in Teaching and Practice of PsychiatryDimy Fluyau
Frontiers in Psychiatry|May 10, 2017
Biochemical Benefits, Diagnosis, and Clinical Risks Evaluation of KratomDimy Fluyau, Neelambika Revadigar
The American Journal on Addictions|December 8, 2020
Systematic Review and Meta-Analysis: Treatment of Substance Use Disorder in Attention Deficit Hyperactivity DisorderDimy Fluyau, Neelambika Revadigar, Christopher G Pierre
Drug and Alcohol Dependence|January 25, 2020
Clinical benefits and risks of N-methyl-d-aspartate receptor antagonists to treat severe opioid use disorder: A systematic reviewDimy Fluyau, Neelambika Revadigar, Christopher G Pierre
Therapeutic Advances in Psychopharmacology|May 2, 2018
Challenges of the pharmacological management of benzodiazepine withdrawal, dependence, and discontinuationDimy Fluyau, Neelambika Revadigar, Brittany E Manobianco
European Journal of Clinical Pharmacology|June 28, 2023
Beyond benzodiazepines: a meta-analysis and narrative synthesis of the efficacy and safety of alternative options for alcohol withdrawal syndrome managementDimy Fluyau, Vasanth Kattalai Kailasam, Christopher G Pierre
Journal of Psychopharmacology (Oxford, England)|January 17, 2023
A Bayesian meta-analysis of topiramate's effectiveness for individuals with alcohol use disorderDimy Fluyau, Vasanth Kattalai Kailasam, Christopher G Pierre
International Clinical Psychopharmacology|February 27, 2025
Selective serotonin reuptake inhibitors and quality of life: a meta-analysis of randomized placebo-controlled trialsDimy Fluyau, Vasanth Kattalai Kailasam, Paul Kim, et al.
Pageof 2